Y-Intercept (HK)’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-228,794
Closed -$325K 1657
2022
Q4
$325K Buy
+228,794
New +$491K 0.05% 622
2022
Q2
Sell
-11,296
Closed -$76K 1284
2022
Q1
$76K Buy
+11,296
New +$96.6K 0.02% 682

Other funds holding DBD

Y-Intercept (HK)'s DBD Position: Q1 2023 in Review

Y-Intercept (HK) sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 228,794 shares — an estimated $325K sold.

Y-Intercept (HK) first reported a position in DBD in Q1 2022 and held it in 2 quarters. The position peaked at $325K in Q4 2022. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Y-Intercept (HK) reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 228,794 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $325K.
  • Y-Intercept (HK) first reported a position in Diebold Nixdorf Incorporated in Q1 2022 and held it in 2 quarters.
  • Y-Intercept (HK)'s Diebold Nixdorf Incorporated position peaked at $325K in Q4 2022.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.